Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial D Rubino, N Abrahamsson, M Davies, D Hesse, FL Greenway, C Jensen, ... Jama 325 (14), 1414-1425, 2021 | 531 | 2021 |
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial S Del Prato, SE Kahn, I Pavo, GJ Weerakkody, Z Yang, J Doupis, ... The Lancet 398 (10313), 1811-1824, 2021 | 335 | 2021 |
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised … P Dandona, C Mathieu, M Phillip, L Hansen, SC Griffen, D Tschöpe, ... The lancet Diabetes & endocrinology 5 (11), 864-876, 2017 | 302 | 2017 |
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study P Dandona, C Mathieu, M Phillip, L Hansen, D Tschöpe, F Thorén, J Xu, ... Diabetes Care 41 (12), 2552-2559, 2018 | 223 | 2018 |
Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis MP Ocaranza, J Moya, V Barrientos, R Alzamora, D Hevia, C Morales, ... Journal of hypertension 32 (4), 771-783, 2014 | 116 | 2014 |
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled … M von Herrath, SC Bain, B Bode, JO Clausen, K Coppieters, L Gaysina, ... The Lancet Diabetes & Endocrinology 9 (4), 212-224, 2021 | 87 | 2021 |
Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease Z Zhou, MJ Jardine, Q Li, BL Neuen, CP Cannon, D De Zeeuw, ... Stroke, 2021 | 71 | 2021 |
Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: a randomized clinical trial in … A Philis‐Tsimikas, LK Billings, R Busch, CM Portillo, R Sahay, N Halladin, ... Diabetes, Obesity and Metabolism 21 (6), 1399-1408, 2019 | 63 | 2019 |
Practical approach to initiating SGLT2 inhibitors in type 2 diabetes F Gomez-Peralta, C Abreu, A Lecube, D Bellido, A Soto, C Morales, ... Diabetes Therapy 8, 953-962, 2017 | 62 | 2017 |
Incidence and care‐related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project RJ Barranco, F Gomez‐Peralta, C Abreu, M Delgado, R Palomares, ... Diabetic Medicine 32 (11), 1520-1526, 2015 | 57 | 2015 |
Diabetes and periodontal diseases: an established two-way relationship CA Molina, LF Ojeda, MS Jiménez, CM Portillo, IS Olmedo, ... Journal of Diabetes Mellitus 6 (4), 209-229, 2016 | 53 | 2016 |
Increased salivary oxidative stress parameters in patients with type 2 diabetes: relation with periodontal disease C Arana, AM Moreno-Fernández, G Gómez-Moreno, C Morales-Portillo, ... Endocrinología, Diabetes y Nutrición (English ed.) 64 (5), 258-264, 2017 | 43 | 2017 |
Patients’ and physicians’ preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment C Morillas, R Feliciano, PF Catalina, C Ponte, M Botella, J Rodrigues, ... Patient preference and adherence, 1443-1458, 2015 | 34 | 2015 |
Once-weekly efpeglenatide dose-range effects on glycemic control and body weight in patients with type 2 diabetes on metformin or drug naive, referenced to liraglutide J Rosenstock, CH Sorli, ME Trautmann, C Morales, U Wendisch, G Dailey, ... Diabetes Care 42 (9), 1733-1741, 2019 | 33 | 2019 |
Clinical approach to flash glucose monitoring: an expert recommendation A Chico, E Aguilera, FJ Ampudia-Blasco, V Bellido, ... Journal of diabetes science and technology 14 (1), 155-164, 2020 | 28 | 2020 |
Compatibility and safety of ultra rapid lispro with continuous subcutaneous insulin infusion in patients with type 1 diabetes: PRONTO-Pump Study BW Bode, SK Garg, P Norwood, C Morales, T Hardy, R Liu, D Ignaut Diabetes technology & therapeutics 23 (1), 41-50, 2021 | 27 | 2021 |
De la diabetes a la insuficiencia cardiaca¿ Existe la miocardiopatía diabética? C Saldarriaga-Giraldo, V Navas, C Morales Revista Colombiana de Cardiología 27, 12-16, 2020 | 15 | 2020 |
Anti-IL-21–Liraglutide Study Group Investigators and Contributors. Anti-interleukin-21 antibody and liraglutide for the preservation of b-cell function in adults with recent … M von Herrath, SC Bain, B Bode, JO Clausen, K Coppieters, L Gaysina, ... Lancet Diabetes Endocrinol 9, 212-224, 2021 | 14 | 2021 |
Eficacia de una estrategia para mejorar los indicadores de calidad del Proceso Asistencial Integrado Diabetes Mellitus 2 en el Centro Avanzado de Diabetes Macarena JM Vélez, R García, E Pina, C Morales, C Escalera, A Ortega, B Poyatos, ... Atención Primaria 51 (1), 18-23, 2019 | 13 | 2019 |
Effectiveness and safety of insulin glargine 300 U/ml in comparison with insulin degludec 100 U/ml evaluated with continuous glucose monitoring in adults with type 1 diabetes … I Conget, MÁ Mangas, C Morales, J Caro, M Giménez, M Borrell, ... Diabetes Therapy 12, 2993-3009, 2021 | 12 | 2021 |